NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/13/2025
Back to search
Official data from USPTO
CLINICAL LEADERS IN OBESITY MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL LEADERS IN OBESITY MEDICINE
ST13
US500000086327333Class
35, 41
Filing
86327333
Registration
4673284
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/08/2025
Trademark type
Word
Nice classes
35, 41
Filing date
07/02/2014
Registration date
01/13/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/03/2014
First use in commerce
11/03/2014
Drawing code
4
Owner type
99
Owner location
DENVER, CO
Examiner
SMITH, CYNTHIA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OBESITY MEDICINE ASSOCIATION
A. P. (pessoa física)
Representatives
David M. Abrahams Webster, Chamberlain & Bean, LLP
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Association servicespromoting the interests of physicians who specialize in the medical treatment of obesity
Class 41
Educational servicesconducting programs in the field of obesity evaluation and treatmentdistribution of course materials in connection therewith; providing training in the medical management of obesity
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/13/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
01/07/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/13/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/07/2020
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/07/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2020
ES8R
TEAS SECTION 8 RECEIVED
02/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/19/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/13/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/28/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/28/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/16/2015
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/13/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/08/2014
ALIE
ASSIGNED TO LIE
12/08/2014
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/24/2014
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11/22/2014
IUAA
USE AMENDMENT ACCEPTED
11/21/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2014
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/20/2014
IUAF
USE AMENDMENT FILED
11/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2014
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/19/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2014
GNRT
NON-FINAL ACTION E-MAILED
10/10/2014
CNRT
NON-FINAL ACTION WRITTEN
10/10/2014
DOCK
ASSIGNED TO EXAMINER
10/10/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2014
NWAP
NEW APPLICATION ENTERED
07/05/2014
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL LEADERS IN OBESITY MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.